logo
  Join        Login             Stock Quote

Becton, Dickinson's (BDX) System For RSV Testing Gets 510(K) Approval

 October 11, 2012 03:37 PM
 


(By Balachander) Becton, Dickinson and Co.'s (NYSE:BDX) system for rapid detection of respiratory syncytial virus (RSV) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens, says Alverix Inc.

Alverix collaborated with Becton in the development of the BD Veritor System for rapid detection of Flu A+B. BD selected Alverix to design, develop and supply the digital reader component of BDX unit's new Point-of-Care (POC) diagnostic system.

According to Alverix, the BD Veritor System for Rapid Detection of RSV joins the FDA-approved and CLIA-waived BD Veritor System assays for rapid detection of Flu A+B. This assay for rapid detection of RSV on the BD Veritor System represents the third offering of many planned assays on this new platform.

[Related -3 Styles Of Successful Dividend Investing]

The BD Veritor System provides objective tests results on an easy to read display, Alverix said.

"The clearance of the new BD Veritor System kit specifically for RSV testing in clinical settings is a significant addition to the BD Veritor upper respiratory infectious disease product line," said Ric Tarbox, CEO of Alverix.

According to the U.S. Centers for Disease Control and Prevention, RSV is the most common cause of pneumonia and bronchiolitis in the United States in children under one year of age.

BDX shares added 0.77 percent to trade at $76.99 on Thursday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageThe $7 Billion Reason To Short Retail

After nine months of fruitless negotiations, the International Longshore and Warehouse Union and the read on...

article imageWhy There Won't Be An Interest Rate Increase Anytime Soon

A market trend reversal due to rising interest rates won’t happen anytime soon because the Fed won’t act in read on...

article imageThe ECB Would Gladly Pay You Tuesday for a Hamburger Today

Will the ECB find enough bonds to meet its quantitative easing read on...

article imageThe Taylor Rule Conundrum

Back in February 2005 Alan Greenspan referred to the abnormal (low) level of US long-term interest rates as read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.